POMC and Cushing syndrome: An ACTH stimulation test confirmed hyperadrenocorticism (pre-ACTH cortisol: 22.1 μg/dL, post-ACTH cortisol: >50 μg/dL), and trilostane (Trilostab; Fujita Pharmaceutical, Tokyo, Japan) (0.4 mg/kg every 12 h) was initiated.